Ambalal Sarabhai Enterprises
AMBALALSABSE

Ambalal Sarabhai Enterprises

₹27.022.21 (8.91%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
24.33
Today’s high
28.00
52 week low
23.12
52 week high
42.00
Open price
24.33
Previous close
24.81
Live volume
2,98,446
Lower circuit
21.62
Upper circuit
32.42

Fundamentals

Market Cap
₹207Cr
ROE
10.60%
P/E Ratio(TTM)
18.76
EPS(TTM)
1.44
P/B Ratio
1.40
Dividend Yield
0.00%
Industry P/E
32.86
Book Value
19.25
Debt to Equity
0.32
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Ambalal Sarabhai Enterprises Limited is a diversified company with core operations in the pharmaceuticals and electronics manufacturing sectors, supported by its subsidiaries and joint ventures. Its focused subsidiaries have recorded significant progress in key areas including Active Pharmaceutical Ingredients manufacturing, Molecular Diagnostics, and niche Effervescent products. The group maintains a clear emphasis on disease-based solutions, leveraging its robust technological capabilities to drive future growth in both healthcare and electronics. Its joint venture, Vovantis, operates a USFDA-approved manufacturing plant in Ranoli, with an increased focus on products for the USA and European markets. Another key subsidiary, Synbiotics, is a USFDA inspected company that manufactures an antifungal active ingredient, Amphotericin B, for an expanding global market. Furthermore, its Asence subsidiary specializes in supplying quality pharmaceutical preparations to international markets, with over 100 products registered worldwide.;
MD/CEO
Mr. Mohal K. Sarabhai
Founded in
1977
BSE symbol
500009

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Retail And Others
68.29%
Promoters
31.36%
Foreign Institutions
0.34%
Other Domestic Institutions
0.01%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,121.80
-9.60 (0.45%)
L
    H
    34,067.3545.198.95
    ₹1,438.00
    -76.20 (5.03%)
    L
      H
      27,247.8130.455.75
      WockhardtWOCKPHARMA
      ₹1,211.30
      -87.30 (6.72%)
      L
        H
        19,685.11-1953.954.31
        Natco PharmaNATCOPHARM
        ₹955.85
        -60.35 (5.94%)
        L
          H
          17,132.7511.011.98
          2026
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          11
          Aug
          Quarterly Result
          Release date
          30
          May
          Annual Result
          Release date
          14
          Feb
          Quarterly Result
          Release date
          2024
          12
          Nov
          Quarterly Result
          Release date
          9
          Aug
          Quarterly Result
          Release date
          24
          May
          Result
          Release date
          Events calendar
          View upcoming events in other stocks